DIGE Digene Corp (MM)

GAITHERSBURG, Md., April 24 /PRNewswire-FirstCall/ -- Digene Corporation (NASDAQ:DIGE) today announced plans to release financial results for the fiscal 2007 third quarter and nine months ended March 31, 2007 at the close of market on Tuesday, May 8, 2007. Digene will host a conference call, which will be broadcast live over the Internet on Tuesday, May 8, 2007 at 4:30 p.m. EDT. The broadcast will be hosted on the Company's website located at http://www.digene.com/. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast. The online archive of the broadcast will be available within two hours of the live call and can be accessed through August 8, 2007, by dialing (800) 642-1687 or (706) 645-9291. About Digene A leader in molecular diagnostics, Digene develops, manufactures and markets proprietary DNA and RNA tests, with a focus on women's health. The company's flagship product, the Digene(R) HPV Test, is the only FDA-approved and CE-marked test for the human papillomavirus, the cause of essentially all cervical cancers. Digene's product portfolio also includes tests for the detection of other sexually transmitted infections, including chlamydia and gonorrhea. Digene tests are marketed in more than 40 countries worldwide. Headquartered in Gaithersburg, MD, Digene is traded on NASDAQ under the symbol DIGE. For more information, visit http://www.digene.com/ and http://www.thehpvtest.com/. DATASOURCE: Digene Corporation CONTACT: Albert Fleury, Investor Relations, +1-301-944-7000, Investors and Media, Pam Rasmussen, +1-301-944-7196, both of Digene Corporation Web site: http://www.digene.com/

Copyright